FR2125435B1 - - Google Patents

Info

Publication number
FR2125435B1
FR2125435B1 FR7204789A FR7204789A FR2125435B1 FR 2125435 B1 FR2125435 B1 FR 2125435B1 FR 7204789 A FR7204789 A FR 7204789A FR 7204789 A FR7204789 A FR 7204789A FR 2125435 B1 FR2125435 B1 FR 2125435B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7204789A
Other languages
French (fr)
Other versions
FR2125435A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Czech Academy of Sciences CAS
Original Assignee
Czech Academy of Sciences CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Czech Academy of Sciences CAS filed Critical Czech Academy of Sciences CAS
Publication of FR2125435A1 publication Critical patent/FR2125435A1/fr
Application granted granted Critical
Publication of FR2125435B1 publication Critical patent/FR2125435B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7204789A 1971-02-12 1972-02-14 Antiarhythmic organomercuric cpds - esp fluorescein derivs Granted FR2125435A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS109171 1971-02-12

Publications (2)

Publication Number Publication Date
FR2125435A1 FR2125435A1 (en) 1972-09-29
FR2125435B1 true FR2125435B1 (enExample) 1975-10-10

Family

ID=5344368

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7204789A Granted FR2125435A1 (en) 1971-02-12 1972-02-14 Antiarhythmic organomercuric cpds - esp fluorescein derivs

Country Status (1)

Country Link
FR (1) FR2125435A1 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1169998A (en) * 1966-04-06 1969-11-12 Ceskoslovenska Akademie Ved Radioactive Substituted Derivatives of the Fluorescein Series and Method of Producing Same
FR1517566A (fr) * 1967-03-03 1968-03-15 Ceskoslovenska Akademie Ved Procédé de préparation de dérivés de la fluorescéine marqués par isotopes radioactifs du mercure

Also Published As

Publication number Publication date
FR2125435A1 (en) 1972-09-29

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
AR196074A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2952271A (enExample)
AU2941471A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2485671A (enExample)
AU2684071A (enExample)
AU3005371A (enExample)
AU2564071A (enExample)
AU2473671A (enExample)
AU2836771A (enExample)
AU3038671A (enExample)
AU2503871A (enExample)
AU3025871A (enExample)
AU2577671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AR192311Q (enExample)
AU2669471A (enExample)
AU2456871A (enExample)
AU2684171A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse